ASX has a new Biotech listing in the coming weeks (pending successful IPO). http://www.recce.com.au/content/page/prospectus.html Pretty serious potential given the magnitude of the superbug resistance problem.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks
AN1 CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch
